North America Chronic Cough Market Key Companies and SWOT Analysis by 2027

The Chronic Cough market in North America is expected to grow from US$ 2,118.42 million in 2019 to US$ 3,944.89 million by 2027. This represents a CAGR of 8.1% from 2020 to 2027.

The growth of the market in the region is expected to grow owing to rising incidences of chronic cough, growing product developments to treat chronic cough. Additionally, robust product pipeline, presence of major players and well-developed regulatory policies are projected to drive the North American chronic cough market during the forecast period.

The US has observed fast growth in the chronic cough market within the past few years and is expected to lead the market in North America during the forecast period. Chronic cough is defined as a persistent cough that lasts long up to 6-8 weeks. It significantly affects the life of the patients by interrupt sleeping, vomiting, light-headedness, and even rib fractures. It is caused due to multiple reasons such as infections, asthma, gastro esophageal reflux disease (GERD), among others. Additionally, , the government initiatives for the treatment, diagnosis and awareness program will further propel the growth in the country. For instance, The Temple Lung Center’s Chronic Cough Program team specializes in finding the cause of your chronic cough and can offer treatments to lessen the cough or address the underlying medical condition. In addition, The Global Initiative for Chronic Obstructive Lung Disease (GOLD) works with health care professionals and public health officials around the world to raise awareness of Chronic Obstructive Pulmonary Disease (COPD) and to improve prevention and treatment of this lung disease.

US Chronic Cough Market Revenue and Forecast to 2027 (US$ Million)

NORTH AMERICA CHRONIC COUGH – MARKET SEGMENTATION

By Drug Class

• Antihistamines
• Corticosteroids
• Decongestants
• Combination Drug
• Antibiotics
• Acid Blockers
• Other Drug Class

By Route of Administration

• Oral
• Injections
• Nasal
• Other Route of Administration

By Distribution Channel

• Hospital Pharmacy
• Online Pharmacy
• Retail Pharmacy

By Country

• US
• Canada
• Mexico

Company Profiles

• Novartis AG
• Teva Pharmaceutical Industries Ltd
• GlaxoSmithKline plc.
• Bayer AG
• Mylan N.V.
• Amneal Pharmaceuticals, Inc.
• Cipla Inc.
• Reckitt Benckiser Group plc.
• Sun Pharmaceutical Industries Ltd
• Aurobindo Pharma Ltd

North America Chronic Cough Report Scope